to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Carcinoma, Pancreatic Ductal
Immuno- and gene-therapeutic strategies targeted against cancer (mainly focusing on pancreatic cancer).
Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer.
Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent.
Young patients undergoing resection of pancreatic cancer fare better than their older counterparts.
Vaccines for pancreatic cancer.
Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma.
Laparoscopic Spleen-Preserving Total Pancreatectomy for a Main-Duct Intraductal Papillary Mucinous Neoplasm.
PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.
Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma.
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
Vascular invasion in infiltrating ductal adenocarcinoma of the pancreas can mimic pancreatic intraepithelial neoplasia: a histopathologic study of 209 cases.
Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT.
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer.
Diffuse replacement of pancreatic parenchyma by intraductal papillary mucinous neoplasm.
Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer.
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma.
Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model.
Carcinoma Pancreatic Ductal